期刊文献+

BNP、CRP与急性心肌梗死并发恶性室性心律失常的相关分析 被引量:23

Brain natriuretic peptid,C-reactive protein and acute myocardial infraction with ventricular tachyarrhythmias
原文传递
导出
摘要 目的:探讨急性心肌梗死(AMI)患者合并恶性室性心律失常的危险因素。方法:回顾性分析我院接受急诊冠状动脉介入(PCI)的ST段抬高心肌梗死患者322例。分为恶性室性心律失常组(A组)68例和无恶性室性心律失常组(B组)254例。通过观察比较患者的一般临床情况,进行心脏超声检查,检测生化指标、C反应蛋白(CRP)及血浆脑钠肽(BNP)。并将可能的相关因素进行Logist多因素回归分析。结果:两组患者在年龄、性别构成、高血压、陈旧心肌梗死、既往血运重建病史、基础心率、血压等方面具有可比性。但A组患者的空腹血糖、CRP及BNP水平明显高于B组患者[空腹血糖(8.83±4.81)mmol/L∶(6.02±2.25)mmol/L,P=0.012;CRP(18.24±12.19)mg/L∶(11.06±10.06)mg/L,P=0.016;BNP(446.04±146.37)pg/L∶(315.01±121.11)pg/L,P=0.009]。Logist多因素回归分析示:BNP、CRP的升高是AMI患者合并恶性室性心律失常的独立危险因素(BNP:OR=1.416,95%CI:0.921~3.012,P=0.021;CRP:OR=1.367,95%CI:1.040~4.312,P=0.015)。结论:AMI患者BNP、CRP水平的升高可能预示发生恶性室性心律失常风险的增加。 Objective:To explore the risk factors in patients with acute myocardial infarction complicated with malignant ventricular arrhythmia.Method:The study was a retrospective analysis of 322 STEMI patients received primary percutaneous coronary intervention(PPCI)in our hospital from 2010 June to 2012 December.According to malignant ventricular arrhythmia,all patients were divided into:malignant ventricular arrhythmia group(A group),68cases;non malignant ventricular arrhythmia group(B group),254 cases.We observed and compared the two groups patients in general clinical conditions,cardiac ultrasound examination,biochemical indicator detection,C reactive protein(CPR)and plasma brain natriuretic peptide(BNP).Logistic multi-factors regression analysis was performed.Rusult:There were no significant difference between A group with B group in aspects:age,sex,hypertension,old myocardial infarction,previous revascularization,heart rate,blood pressure,et al.There were significant differences in aspects:fasting plasma glucose(8.83±4.81)vs(6.02±2.25)mmol/L,P=0.012;CRP(18.24±12.19)vs(11.06±10.06)mg/L,P=0.016;BNP(446.04±146.37)vs(315.01±121.11)pg/L,P=0.009).The logistic regression analysis demonstated:BNP(OR1.416,95% CI 0.921-3.012,P=0.021)and CRP(OR1.367,95%CI 1.040-4.312,P=0.015)were independent risk factors of acute myocardial infraction patients with ventricular tachyarrhythmias.Conclusion:BNP and CRP are independent risk factors of acute myocardial infraction patients with malignant ventricular tachyarrhythmias.It may indicate malignant ventricular arrhythmia incidence increase that the level of CRP and BNP elevated in patients with acute myocardial infarction.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2014年第11期983-986,共4页 Journal of Clinical Cardiology
关键词 急性心肌梗死 恶性室性心律失常 C反应蛋白 脑钠肽 acute myocardial infraction malignant ventricular arrhythmia C reactive protein brain natri-uretic peptid
  • 相关文献

参考文献13

  • 1FOX K A,ANDERSON F A JR, DABBOUS O H, et al. Intervention in acute coronary syndromes., do pa- tients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coro- nary Events (GRACE)[J]. Heart, 2007, 93 : 177-- 182.
  • 2KANEKO H, ANZAI T, NAITO K, et al. Role of ischemic preconditioning and inflammatory response in the development of malignant ventricular arrhythmias after reperfused ST-elvation myocardial infarction[J]. J Card Fail., 2009, 15: 775--781.
  • 3陈俊华,张淳,于娜.C1酯酶抑制剂对大鼠急性心肌缺血再灌注损伤的保护作用[J].中华老年心脑血管病杂志,2011,13(9):831-834. 被引量:4
  • 4PEPYS M B, HIRSCHFIELD G M, TENNENT GA, et al. Targeting C-reactive protein for the treat- ment of cardiovascular disease[J]. Nature, 2006, 440:1217--1221.
  • 5CHUNG M K, MARTIN D O, SPRECHER D, et al. C-reactive protein elevation in patients with atrial arrhythmias; inflammatory mechanisms and persist- ence of atrial fibrillation [J]. Circulation, 2001,104: 2886--2891.
  • 6VYAS A K, GUO H, MOSS A J, et al. Reduction in ventricular tachyarrhythmias with statins in the MAD- IT II trial [J]. J Am Coll Cardiol, 2006, 47:769-- 773.
  • 7MITCHELL L B, POWELL J L, GILLIS A M, et al. Are lipid-lowering drugs also anti-arrhythmic drugs[J]. J Am Coil Cardiol, 2003, 42: 81--87.
  • 8ABREU C D, NUNES MDO C, BARBOSA M M, et al. Venticular dyssynchrony and increased BNP levels in right ventricular apical pacing[J]. Arq Bras Cardi- ol, 2011, 97: 156--162.
  • 9BLANGY H, SADOUL N, DOUSSET B, et al. Ser- um BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients af- ter myocardial infarction[J]. Europace, 2007, 9:724 --729.
  • 10SANJUAN R, BLASCO M L, MARTINEZ-MAI- CAS H, et al. Acute myocardial infarction: high risk ventricular tachyarrhythmias and admission glucose level in patients with and without diabetes mellitus [J] Curr Diabetes Rev, 2011, 7:126--134.

二级参考文献7

  • 1张沛,杨跃进,宋来凤,阮英茆,周燕文,田毅,陈纪林,陈在嘉,徐义枢.小剂量依那普利对大鼠急性心肌梗死左室重构和功能的影响[J].中华老年心脑血管病杂志,2000,2(6):408-411. 被引量:11
  • 2邱振宇,周盾.细胞间黏附分子-1与肾缺血再灌注损伤[J].基础医学与临床,2007,27(1):100-104. 被引量:4
  • 3Shagdarsuren E, Bidzhekov K, Djalali Talab Y, et al. C1 -esterase inhibitor protects against neointima formation after arteria injury in atherosclerosis-prone mice. Circulation, 2008,117 : 70- 78.
  • 4Tanhehco EJ,Kilgore KB, Naylor KB, et al. Reduction of myo cardial infarct size after ischemia and reperfusion by the glyco saminoglycan polysulfate. Science, 1999,34 : 153-161.
  • 5Souzar-Moraes MR, David Filho R, Baptista Silva JC, et al. Effect of antibodies to intercellular adhesion molecule type 1 on the protection of distant organs during reperfusion syndrome in rats. Braz J Med Biol Res,2009,36:605- 612.
  • 6Brook E, Herbert AP,Jenkins HT,et al. Opportunities for new therapies based on the natural regulators of complement activation. Ann N Y Acad Sci,2005,1056:176-188.
  • 7Horstick G, Berg O, Herbert A, et al. Application of Cl-esterase inhibitor during reperfusion of ischemie myocardium: doserelated beneficial versus detrimental effects. Circulation, 2010, 104:3125-3131.

共引文献3

同被引文献206

引证文献23

二级引证文献124

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部